HER-Vaxx Cancer Vaccine — Vax-Before-Travel

HER-Vaxx Cancer Vaccine

Fact checked by Robert Carlson, MD

Oct 3

3 min read

Anti-Cancer Vaccine Presented Positive Phase 1 Results

HER-Vaxx is a B-cell peptide cancer vaccine candidate designed to treat tumors that over-express the HER-2/neu receptor

woman raising hands towards the sky in celebration

Fact checked by Robert Carlson, MD

Jul 8

4 min read

HER-Vaxx Cancer Vaccine Published New Clinical Data

Imugene Limited HER-Vaxx (IMU-131) is a B-cell peptide cancer vaccine designed to treat tumors that over-express the HER-2/neu receptor

yoga on the beach

Fact checked by Robert Carlson, MD

Jun 5

3 min read

HER-Vaxx Cancer Vaccine Reports Positive Results

Imugene’s IMU-131 HER-Vaxx is a B-cell peptide cancer vaccine candidate in phase 2 study

Women in a yoga class, healthy living